These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12070830)

  • 21. Infections due to emerging and uncommon medically important fungal pathogens.
    Walsh TJ; Groll A; Hiemenz J; Fleming R; Roilides E; Anaissie E
    Clin Microbiol Infect; 2004 Mar; 10 Suppl 1():48-66. PubMed ID: 14748802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.
    Michallet M; Ito JI
    J Clin Oncol; 2009 Jul; 27(20):3398-409. PubMed ID: 19487382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome.
    Morrison VA; Haake RJ; Weisdorf DJ
    Am J Med; 1994 Jun; 96(6):497-503. PubMed ID: 8017446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endemic mycoses in patients with hematologic malignancies.
    Kauffman CA
    Semin Respir Infect; 2002 Jun; 17(2):106-12. PubMed ID: 12070829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging fungal infections in solid organ transplant recipients.
    Shoham S
    Infect Dis Clin North Am; 2013 Jun; 27(2):305-16. PubMed ID: 23714342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic methodologies for invasive fungal infections in hematopoietic stem-cell transplant recipients.
    Somboonwit C; Greene JN
    Semin Respir Infect; 2002 Jun; 17(2):151-7. PubMed ID: 12070834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The spectrum of non-Candida fungal infections following bone marrow transplantation.
    Morrison VA; Haake RJ; Weisdorf DJ
    Medicine (Baltimore); 1993 Mar; 72(2):78-89. PubMed ID: 8479326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging and less common fungal pathogens.
    Fleming RV; Walsh TJ; Anaissie EJ
    Infect Dis Clin North Am; 2002 Dec; 16(4):915-33, vi-vii. PubMed ID: 12512187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
    Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uncommon opportunistic fungi: new nosocomial threats.
    Groll AH; Walsh TJ
    Clin Microbiol Infect; 2001; 7 Suppl 2():8-24. PubMed ID: 11525222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.
    Marr KA; Carter RA; Crippa F; Wald A; Corey L
    Clin Infect Dis; 2002 Apr; 34(7):909-17. PubMed ID: 11880955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disseminated Ochroconis gallopavum infection in a chronic lymphocytic leukemia: a case report and review of the literature on hematological malignancies.
    Fukushima N; Mannen K; Okamoto S; Shinogi T; Nishimoto K; Sueoka E
    Intern Med; 2005 Aug; 44(8):879-82. PubMed ID: 16157992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of mycoses in patients with hematologic disease and cancer -- review of the literature.
    Ruhnke M; Maschmeyer G
    Eur J Med Res; 2002 May; 7(5):227-35. PubMed ID: 12069913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opportunistic deep cutaneous mycoses in solid organ transplant recipients.
    Tessari G; Cagalli A; Girolomoni G
    G Ital Dermatol Venereol; 2014 Aug; 149(4):417-22. PubMed ID: 25068229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New spectrum of fungal infections in patients with cancer.
    Anaissie E; Bodey GP; Kantarjian H; Ro J; Vartivarian SE; Hopfer R; Hoy J; Rolston K
    Rev Infect Dis; 1989; 11(3):369-78. PubMed ID: 2749101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.
    Huijgens PC; Simoons-Smit AM; van Loenen AC; Prooy E; van Tinteren H; Ossenkoppele GJ; Jonkhoff AR
    J Clin Pathol; 1999 May; 52(5):376-80. PubMed ID: 10560360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opportunistic fungal pneumonia.
    Connolly JE; McAdams HP; Erasmus JJ; Rosado-de-Christenson ML
    J Thorac Imaging; 1999 Jan; 14(1):51-62. PubMed ID: 9894953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive Fungal Pneumonia in Immunocompromised Patients.
    Godoy MCB; Ferreira Dalla Pria HR; Truong MT; Shroff GS; Marom EM
    Radiol Clin North Am; 2022 May; 60(3):497-506. PubMed ID: 35534133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fungal Pneumonia in Patients with Hematologic Malignancy and Hematopoietic Stem Cell Transplantation.
    Young AY; Leiva Juarez MM; Evans SE
    Clin Chest Med; 2017 Sep; 38(3):479-491. PubMed ID: 28797490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.